CymaBay Therapeutics, Inc.
NASDAQ:CBAY
32.48 (USD) • At close March 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 206.535 | 20.291 | 125.806 | 28.193 | 24.869 | 48.995 | 23.054 | 10.495 | 7.706 | 11.586 | 24.401 | 7.726 |
| Short Term Investments
| 187.72 | 115.194 | 60.729 | 118.13 | 166.076 | 129.669 | 74.156 | 6.499 | 33.774 | 23.209 | 6.843 | 0 |
| Cash and Short Term Investments
| 394.255 | 135.485 | 186.535 | 146.323 | 190.945 | 178.664 | 97.21 | 16.994 | 41.48 | 34.795 | 31.244 | 7.726 |
| Net Receivables
| 0 | 0 | 0 | 0.277 | 0.687 | 0 | 5 | 0 | 0.186 | 0.347 | 0.178 | 0.117 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 1.208 | 0 | 0 | 1.991 | 0.364 | 0 |
| Other Current Assets
| 9.547 | 2.588 | 4.564 | 4.985 | 11.291 | 0.304 | 0.126 | 0.165 | 1.128 | 0.096 | 0.453 | 0.147 |
| Total Current Assets
| 403.802 | 138.073 | 191.099 | 151.585 | 202.923 | 181.562 | 103.544 | 18.528 | 42.794 | 37.229 | 32.239 | 7.99 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 5.725 | 0.87 | 1.432 | 2.033 | 2.644 | 2.905 | 0.069 | 0.077 | 0.064 | 0.086 | 0.003 | 0.084 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 22.36 | 0 | 8.067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.799 | 2.909 | 1.72 | 0.207 | 0.16 | 2.28 | 0.634 | 0.754 | 0.221 | 0.159 | 0.258 | 0.042 |
| Total Non-Current Assets
| 30.884 | 3.779 | 11.219 | 2.24 | 2.804 | 5.185 | 0.703 | 0.831 | 0.285 | 0.245 | 0.261 | 0.126 |
| Total Assets
| 434.686 | 141.852 | 202.318 | 153.825 | 205.727 | 186.747 | 104.247 | 19.359 | 43.079 | 37.474 | 32.5 | 8.116 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 3.828 | 1.096 | 2.728 | 0.231 | 2.503 | 1.973 | 1.311 | 0.899 | 1.008 | 2.085 | 0.697 | 0.657 |
| Short Term Debt
| 10.007 | 0.664 | 0.567 | 0.482 | 0.407 | 0 | 3.108 | 2.7 | 0.509 | 1.355 | 0.038 | 13.737 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 1.689 | 0 | 0 | 0 | 0 | 0 | 5.8 | 4.567 | 3.409 | 3.423 | 1.834 | 0 |
| Other Current Liabilities
| 21.319 | 13.681 | 15.071 | 9.144 | 14.726 | 12.442 | 6.091 | 1.145 | 1.22 | 13.596 | 6.919 | 3.556 |
| Total Current Liabilities
| 36.843 | 15.441 | 18.366 | 9.857 | 17.636 | 14.415 | 16.31 | 9.311 | 6.146 | 20.459 | 9.488 | 17.95 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 99.172 | 90.257 | 51.015 | 1.262 | 1.743 | 0 | 2.99 | 6.098 | 8.799 | 3.152 | 4.407 | 0 |
| Deferred Revenue Non-Current
| 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -93.857 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 99.172 | 0 | 0 | 0 | 0 | 1.914 | 0 | 0.013 | 0.019 | 0.013 | 0.009 | 318.733 |
| Total Non-Current Liabilities
| 105.587 | 90.257 | 51.015 | 1.262 | 1.743 | 1.914 | 2.99 | 6.111 | 8.818 | 3.165 | 4.416 | 318.733 |
| Total Liabilities
| 142.43 | 105.698 | 69.381 | 11.119 | 19.379 | 16.329 | 19.3 | 15.422 | 14.964 | 23.624 | 13.904 | 336.683 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.5 | 0 |
| Common Stock
| 0.011 | 0.008 | 0.008 | 0.007 | 0.007 | 0.006 | 0.004 | 0.002 | 0.002 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -978.227 | -872.857 | -766.856 | -676.858 | -625.872 | -523.064 | -450.516 | -422.959 | -396.288 | -380.759 | -348.842 | -329.48 |
| Accumulated Other Comprehensive Income/Loss
| 0.144 | -0.326 | -0.013 | 0.008 | 0.08 | -0.058 | -0.044 | -0.001 | -0.021 | -0.014 | 0.002 | 0 |
| Other Total Stockholders Equity
| 1,270.328 | 909.329 | 899.798 | 819.549 | 812.133 | 693.534 | 535.503 | 426.895 | 424.422 | 394.622 | 334.935 | 0.913 |
| Total Shareholders Equity
| 292.256 | 36.154 | 132.937 | 142.706 | 186.348 | 170.418 | 84.947 | 3.937 | 28.115 | 13.85 | 18.596 | -328.567 |
| Total Equity
| 292.256 | 36.154 | 132.937 | 142.706 | 186.348 | 170.418 | 84.947 | 3.937 | 28.115 | 13.85 | 18.596 | -328.567 |
| Total Liabilities & Shareholders Equity
| 434.686 | 141.852 | 202.318 | 153.825 | 205.727 | 186.747 | 104.247 | 19.359 | 43.079 | 37.474 | 32.5 | 8.116 |